• Manufacturer: Hetero Healthcare (India)
• Composition: BIC 50mg / FTC 200mg / TAF 25mg
• Pack Size: 30 tablets
• Indication: HIV-1 treatment (first-line therapy)
This is a high-quality generic version of Biktarvy, a complete once-daily treatment for HIV-1 infection. Manufactured by leading Indian pharmaceutical companies such as Hetero or Cipla, this formulation is widely used and trusted in many countries as a cost-effective alternative to the branded version.
**Composition:**
Each tablet contains:
– Bictegravir 50 mg
– Emtricitabine (FTC) 200 mg
– Tenofovir Alafenamide (TAF) 25 mg
**Indication:**
First-line antiretroviral therapy for the treatment of HIV-1 infection in adults and adolescents.
**Pack Size:**
30 tablets per bottle (1 month supply)
**Manufacturer:**
Hetero Healthcare / Cipla Ltd. (India)
**Usage Instructions:**
Take one tablet orally once a day, with or without food. Always follow your physician’s advice.
**Storage:**
Store in a cool, dry place away from direct sunlight. Keep out of reach of children.
**Disclaimer:**
This is a generic medication equivalent in active ingredients and efficacy to the branded Biktarvy, but not manufactured by Gilead Sciences.